Yellin A E, Heseltine P N, Berne T V, Appleman M D, Gill M A, Riggio C E, Chenella F C
Surg Gynecol Obstet. 1985 Oct;161(4):303-7.
A prospective, randomized, double-blinded comparison of Sulbactam and ampicillin and clindamycin and gentamicin is described. The combination of ampicillin and Sulbactam was not as effective in the management of perforated appendicitis and gangrenous appendicitis as was clindamycin and gentamicin. While both combinations of antibiotics had good anaerobic activity and failures were not associated with the recovery of Bacteroides fragilis group organisms, infectious complications were seen in patients from whom Pseudomonas were isolated. These pseudomonads were not nosocomially acquired and were found especially in patients with perforated appendicitis. We concluded that the combination of clindamycin and gentamicin, although less convenient to administer to the patient, remains the adjunctive antibiotic management of choice for perforated or gangrenous appendicitis. The epidemiologic factors of Pseudomonas species as a primary pathogen in peritonitis deserves further attention.
本文描述了舒巴坦与氨苄西林以及克林霉素与庆大霉素的前瞻性、随机、双盲比较。氨苄西林与舒巴坦联合用药在治疗穿孔性阑尾炎和坏疽性阑尾炎方面不如克林霉素与庆大霉素有效。虽然两种抗生素组合均具有良好的抗厌氧活性,治疗失败与脆弱拟杆菌群微生物的复苏无关,但从分离出铜绿假单胞菌的患者中观察到了感染性并发症。这些铜绿假单胞菌并非医院获得性感染,尤其在穿孔性阑尾炎患者中发现。我们得出结论,克林霉素与庆大霉素联合用药虽然给患者用药不太方便,但仍然是穿孔性或坏疽性阑尾炎辅助抗生素治疗的首选。铜绿假单胞菌作为腹膜炎主要病原体的流行病学因素值得进一步关注。